GCP
MTEM

GSA Capital Partners’s Molecular Templates, Inc. MTEM Stock Holding History

GSA Capital Partners’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,679
Closed -$501K – 1929
2022
Q1 		$501K Sell
9,679
-10
-0.1% -$442 0.07% 531
2021
Q4 		$570K Buy
9,689
+7,101
+274% +$532K 0.07% 518
2021
Q3 		$260K Buy
2,588
+15
+0.6% +$1.55K 0.03% 1102
2021
Q2 		$302K Buy
+2,573
New +$337K 0.03% 942
2021
Q1 		– Sell
-2,529
Closed -$356K – 1603
2020
Q4 		$356K Buy
2,529
+1,756
+227% +$259K 0.06% 646
2020
Q3 		$127K Buy
+773
New +$137K 0.02% 1100
2015
Q2 		– Sell
-140
Closed -$93K – 2242
2015
Q1 		$93K Buy
140
+57
+69% +$37.5K ﹤0.01% 2024
2014
Q4 		$43K Buy
+83
New +$41.5K ﹤0.01% 1640
2014
Q1 		– Sell
-73
Closed -$56K – 1855
2013
Q4 		$56K Buy
+73
New +$55K ﹤0.01% 1597

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GSA Capital Partners's MTEM Position: Q2 2022 in Review

GSA Capital Partners sold out of Molecular Templates, Inc. (MTEM) in Q2 2022, closing a stake of 9,679 shares — an estimated $501K sold.

GSA Capital Partners first reported a position in MTEM in Q4 2013 and held it in 9 quarters. The position peaked at $570K in Q4 2021. 65 funds tracked by Wall St. Rank hold MTEM as of Q2 2022.

  • GSA Capital Partners reported no remaining Molecular Templates, Inc. position as of Q2 2022 after selling out during the quarter.
  • GSA Capital Partners sold 9,679 Molecular Templates, Inc. shares in Q2 2022, an estimated $501K.
  • GSA Capital Partners first reported a position in Molecular Templates, Inc. in Q4 2013 and held it in 9 quarters.
  • GSA Capital Partners's Molecular Templates, Inc. position peaked at $570K in Q4 2021.
  • 65 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2022.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.